Objective To develop new classification criteria for systemic lupus erythematosus ( SLE )
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …

ContextThere is substantial debate about whether the results of nonrandomized studies are
consistent with the results of randomized controlled trials on the same topic.ObjectivesTo …

Objective End‐stage renal disease (ESRD) is a major consequence of lupus nephritis, but
how this risk has changed over time is unknown. We conducted this systematic review to …

Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …

… (with or without SLE), treatment with LDA (75 – 100 mg/day ) during pregnancy should be
considered. … Efficacy of 150 mg daily versus 100 mg daily of aspirin. … Tektonidou M …

… Furthermore, myotoxicity as side effect of the combination of a statin and prophylactic
colchicine (0.5 mg/day) is rare and routine discontinuation of the statin is not recommended.47 …

… antibodies - Tektonidou - 2009 - Arthritis Care & Research - Wiley Online Library …
Tektonidou had full access to all of the data in the study and takes responsibility for the …

… without APS nephropathy was 1.33 ± 0.51 mg/dl and 0.98 ± 0.45 mg/dl, respectively (P = …
at the time of kidney biopsy was 1.58 ± 0.18 mg/dl. Elevated creatinine levels at the time of …

PURPOSE: We evaluated the prevalence and progression of Libman-Sacks endocarditis in
patients with systemic lupus erythematosus and any association between this valvulopathy …

… 20 mg once daily (with consideration of dose reduction to 15 mg once daily for renal
insufficiency [creatinine clearance 30–49 ml/min] in accordance with the package insert) [4]. The …